Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Teva
Chubb
Express Scripts
Boehringer Ingelheim
Accenture
Medtronic
QuintilesIMS
Novartis

Generated: August 18, 2017

DrugPatentWatch Database Preview

Agouron Company Profile

« Back to Dashboard

What is the competitive landscape for AGOURON, and what generic and branded alternatives to AGOURON drugs are available?

AGOURON has three approved drugs.



Summary for Applicant: Agouron

Patents:0
Tradenames:1
Ingredients:1
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Agouron Pharms
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003RXYesYes► Subscribe► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 1997RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Agouron

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Agouron Pharms
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 1997► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 1997► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003► Subscribe► Subscribe
Agouron Pharms
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Fish and Richardson
Queensland Health
Chubb
AstraZeneca
QuintilesIMS
Accenture
Fuji
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot